Brain-Derived Gangliosides Regulate the Cytokine Production and Proliferation of Activated T Cells

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4333-4340

  Irani, David N ^a,b   Lin, Kuo L ^b   Griffin, Diane E ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GANGLIOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; IONOPHORE; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOBLASTOMA PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PHOSPHORYLATION; T LYMPHOCYTE;

ANIMALS; BRAIN; CYTOKINES; GANGLIOSIDES; INTERFERON TYPE II; INTERLEUKIN-2; IONOPHORES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NF-KAPPA B; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 0030588610     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Ledeen, R. W., and R. K. Yu. 1982. Gangliosides: structure, isolation, and anal-ysis. Methods Enzymol. 83:139.
2. Stults, C. L. M., C. C. Sweeley, and B. A. Macher. 1989. Glycosphingolipids: structure, biological source, and properties. Methods Enzymol. 179:167.
3. Ladisch, S., Z.-L. Wu, S. Feig, L. Ulsh, E. Schwartz, G. Floutsis, F. Wiley, C. Lenarsky, and R. Seeger. 1987. Shedding of GD2 ganglioside by human neuroblastoma. Int. J. Cancer 39:73.
4. Valentino, L. A., and S. Ladisch. 1992. Localization of shed human tumor gangliosides: association with serum lipoproteins. Cancer Res. 52:810.
5. Saqr, H. E., D. K. Pearl, and A. J. Yates. 1993. A review and predictive models of ganglioside uptake by biological membranes. J. Neurochem. 61:395.
6. Skaper, S. D., A. Leon, and G. Toffano. 1989. Ganglioside function in the development and repair of the nervous system. Mol. Neurobiol. 3:173.
7. Cheresh, D. A., M. D. Pierschbacher, M. A. Herzig, and K. Mujoo. 1986. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J. Cell Biol. 102:683.
8. Mamoi, T. 1986. Activation of protein kinase C by ganglioside GM3 in the presence of calcium and 12-O-tetradecanoylphorbol-13-acetate. Biochem. Biophys. Res. Commun. 138:865.
9. Whisler, R. L., and A. J. Yates. 1980. Regulation of lymphocyte responses by human gangliosides. I. Characteristics of inhibitory effects and the induction of impaired activation. J. Immunol. 125:2106.
10. Robb, R. J. 1986. The suppressive effect of gangliosides upon IL-2-dependent proliferation as a function of inhibition of IL-2 receptor association. J. Immunol. 136:971.
11. Berenson, C. S., and J. L. Ryan. 1991. Murine peritoneal macrophage gangliosides inhibit lymphocyte proliferation. J. Leukocyte Biol. 50:393.
12. Offner, H., T. Thieme, and A. A. Vandenbark. 1987. Gangliosides induce selective modulation of CD4 from helper T lymphocytes. J. Immunol. 139:3295.
13. Chu, J. W. K., and F. J. Sharom. 1993. Gangliosides inhibit T-lymphocyte proliferation by preventing the interaction of interleukin-2 with its cell surface receptor. Immunology 79:10.
14. Ladisch, S., R. Li, and E. Olson. 1994. Ceramide structure predicts tumor ganglioside immunosuppressive activity. Proc. Natl. Acad. Sci. USA 91:1974.
15. Ziegler-Heitbrock, H. W. L., E. Kafferlein, J. G. Haas, N. Meyer, M. Strobel, C. Weber, and D. Flieger. 1992. Gangliosides suppress tumor necrosis factor production in human monocytes. J. Immunol. 148:1753.
16. Cavaillon, J.-M., and C. Fitting. 1986. Inhibition of lipopolysaccharide-induced monocyte interleukin-1 secretion by gangliosides. Eur. J. Immunol. 16:1009.
17. Ladisch, S., L. Ulsh, B. Gillard, and C. Wong. 1984. Modulation of the immune response by gangliosides: inhibition of adherent monocyte accessory function in vitro. J. Clin. Invest. 74:2074.
18. Spagnoli, G. C., C. M. Ausiello, G. Sconocchia, D. Adorno, and C. U. Casciani. 1991. Gangliosides potentiate cyclosporin A-induced suppression of allospecific immune responses. Transplant. Proc. 23:342.
19. Wiegandt, H. 1971. Glycosphingolipids. Adv. Lipid Res. 9:249.
20. Hamburger, A., and L. Svennerholm. 1971. Composition of gangliosides and phospholipids of neuronal and glial cell enriched fractions. J. Neurochem. 18: 1821.
21. Byrne, M. C., M. Farooq, M. Sbaschnig-Agler, W. T. Norton, and R. W. Ledeen. 1988. Ganglioside content of astroglia and neurons isolated from maturing rat brain: consideration of the source of astroglial gangliosides. Brain Res. 461:87.
22. Massa, P. T. 1993. Specific suppression of major histocompatibility complex class I and class II genes in astrocytes by brain-enriched gangliosides. J. Exp. Med. 178:1357.
23. Irani, D. N., K.-I. Lin, and D. E. Griffin. Regulation of brain-derived T cells during acute central nervous system inflammation. J. Immunol. In press.
24. Wesselingh, S. L., B. Levine, R. J. Fox, S. Choi, and D. E. Griffin. 1994. Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J. Immunol. 152:1289.
25. Baeuerle, P. A. 1991. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochem. Biophys. Acta 1072:63.
26. Potter, D., C. J. Iarson, P. Eckes, R. M. Schmid, G. J. Nabel, G. L. Verdine, and P. A. Sharpe. 1993. Purification of the major histocompatibility complex class I transcription factor H2TF1. J. Biol. Chem. 268:18882.
27. Laemmli, U. K. 1970. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680.
28. Chao, R., W. Khan, and Y. A. Hannun. 1992. Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine. J. Biol. Chem. 267:23459.
29. Truneh, A., F. Albert, P. Golstein, and A.-M. Schmitt-Verhulst. 1985. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313:318.
30. Schreiber, S. L. 1991. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251:283.
31. Parker, J., G. Caldini, C. Krishnamurti, P. B. Ahrens, and H. Ankel. 1984. Binding of interleukin 2 to gangliosides. FEBS Lett. 170:391.
32. Robb, R. J., A. Munck, and K. A. Smith. 1981. T cell growth factor receptors: quantitation, specificity, and biological relevance. J. Exp. Med. 154:1455.
33. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323.
34. Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097.
35. Dbaibo, G. S., M. Y. Pushkareva, S. Jayadev, J. K. Schwarz, J. M. Horowitz, L. M. Obeid, and Y. A. Hannun. 1995. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc. Natl. Acad. Sci. USA 92:1347.
36. Kaucic, K., A Grovas, R. Li, R. Quinones, and S. Ladisch. 1994. Modulation of human myelopoiesis by human gangliosides. Exp. Hematol. 22:52.
37. Grayson, G., and S. Ladisch. 1992. Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK activity. Cell. Immunol. 139:18.
38. Ladisch, S., H. Becker, and L. Ulsh. 1992 Immunosuppression by human gangliosides. I. Relationship of carbohydrate structure to the inhibition of T cell responses. Biochem. Biophys. Acta 1125:180.
39. Jackson, K. M., A. J. Yates, C. Z. Orosz, and C. C. Whitacre. 1987. Gangliosides suppress the proliferation of autoreactive cells in experimental allergic encephalomyelitis: ganglioside effects on IL-2 activity. Cell. Immunol. 104:169.
40. Hoyos, B., D. W. Ballard, E. Bohnlein, M. Siekevitz, and W. C. Greene. 1989. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science 244:457.
41. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
42. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283.
43. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286.
44. Kopp, E., and S. Ghosh. 1994. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956.
45. Casolaro, V., S. N. Georas, Z. Song, I. D. Zubkoff, S. A. Abdulkadir, D. Thanos, and S. J. Ono. 1995. Inhibition of NF-AT-dependent transcription by NF-κB: implications for differential gene expression in T helper cell subsets. Proc. Natl. Acad. Sci. USA 92:11623.
46. Lederer, J. A., J. S. Liou, M. D. Todd, L. H. Glimcher, and A. H. Lichtman. 1994. Regulation of cytokine gene expression in T helper cell subsets. J. Immunol. 152:77.
47. Cross, S. L., N. F. Halden, M. J. Lenardo, and W. J. Leonard. 1989 Functionally distinct NF-κB binding sites in the immunoglobulin κ and IL-2 receptor α chain genes. Science 244:466.
48. Boumpas, D. T., E. D. Anastassiou, S. A. Older, G. C. Tsokos, D. L. Nelson, and J. E. Balow. 1991. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest. 87:1739.
49. Joseph, C. K., S. D. Wright, W . G. Bornmann, J. T. Randolph, E. R. Kumar, R. Bittman, J. Liu, and R. N. Kolesnick. 1994. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J. Biol. Chem. 269:17606.
50. Obeid, L. M., C. M. Linardic, L. A. Karplak, and Y. A. Hannun. 1993. Programmed cell death induced by ceramide. Science 259:1769.
51. Koike, T., K. Fehsel, J. Zielasek, H. Kolb, and V. Burkart. 1993. Gangliosides protect from TNFα-induced apoptosis. Immunol. Lett. 35:207.
52. Ikeda, T., H. Nakakuma, H. Shionoya, T. Kawaguchi, K. Yamatsu, and K. Takatsuki. 1992. Ganglioside-induced inhibition of in vivo immune responses in mice. Life Sci. 51:847.
53. Inoue, A., C-S. Koh, N. Yanagisawa, T. Taketomi, and Y. Ishihara. 1996. Suppression of Theiler's murine encephalomyelitis virus-induced demyelinating disease by administration of gangliosides. J. Neuroimmunol. 64:45.
54. Irani, D. N., and D. E. Griffin. 1994. Proliferative unresponsiveness of brain-derived T cells in acute viral encephalitis. FASEB J. 8:A245 (Abstr.).
55. Cserr, H. F., and P. M. Knopf. 1992. Cervical lymphatics, the blood-brain barrier, and the immunoreactivity of the brain: a new view. Immunol. Today 13:507.
56. Kennedy, M. K., D. S. Torrance, K. S. Picha, and K. M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496.
57. Merrill, J. E., D. H. Kono, J. Clayton, D. G. Ando, D. R. Hinton, and F. M. Hofman. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10. PL mice. Proc. Natl. Acad Sci. USA 89:574.
58. Khoury, S. J., W. W. Hancock, and H. L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.